Afanix (Afatinib) 40MG – 30 TABLETS


Afatinib (Afanix) is used as the initial treatment for patients who have non-small cell lung cancer (NSCLC) that has spread to other parts of the body. This medication is specifically for those whose tumors show certain genetic mutations called epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations, as confirmed by an FDA-approved test.

Whatsapp +8801922101029